Back
Neurocrine Biosciences Stock Price Chart
How this hedge fund manager trades weekly options
Claim your free training on trading weekly options
Sell
41
NBIX
Neurocrine Biosciences
Last Price:
120.45
Seasonality Move:
9.9%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIX is experiencing selling pressure, which indicates risk of future bearish movement.
Neurocrine Biosciences Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 121.15 | Sell |
| 20-day SMA: | 129.92 | Sell |
| 50-day SMA: | 139.98 | Sell |
| 200-day SMA: | 136.32 | Sell |
| 8-day EMA: | 122.12 | Sell |
| 20-day EMA: | 127.93 | Sell |
| 50-day EMA: | 134.98 | Sell |
| 200-day EMA: | 133.19 | Sell |
Neurocrine Biosciences Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.27 | Sell |
| Relative Strength Index (14 RSI): | 30.83 | Sell |
| Chaikin Money Flow: | -802737 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.79 - 147.07) | Sell |
| Bollinger Bands (100): | (130.14 - 147.58) | Sell |
Neurocrine Biosciences Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neurocrine Biosciences Stock
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 119.85 while NBIX 8-day simple moving average is 121.15, which is a Sell signal.
- The stock price of NBIX is 119.85 while Neurocrine Biosciences 20-day SMA is 129.92, which makes it a Sell.
- Neurocrine Biosciences 50-day simple moving average is 139.98 while NBIX share price is 119.85, making it a Sell technically.
- NBIX stock price is 119.85 and Neurocrine Biosciences 200-day simple moving average is 136.32, creating a Sell signal.
NBIX Technical Analysis vs Fundamental Analysis
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences a Buy or a Sell?
-
Neurocrine Biosciences stock is rated a Sell
The current Neurocrine Biosciences [NBIX] share price is $119.85. The Score for NBIX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Neurocrine Biosciences Stock Info
Market Cap:
12.1B
Price in USD:
119.85
Share Volume:
1.05M
Neurocrine Biosciences 52-Week Range
52-Week High:
157.98
52-Week Low:
103.63
Sell
41
Neurocrine Biosciences (NBIX)
is a Sell
Neurocrine Biosciences Share Price Forecast
-
What is the Neurocrine Biosciences stock price today?
The Neurocrine Biosciences stock price is 119.85 USD today. -
Will NBIX stock go up or go down?
Neurocrine Biosciences> share price is forecast to RISE/FALL based on technical indicators -
Is Neurocrine Biosciences overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neurocrine Biosciences is overvalued.
Is Neurocrine Biosciences Stock a Buy?
- Neurocrine Biosciences share price is 119.85 while NBIX 8-day exponential moving average is 122.12, which is a Sell signal.
- The stock price of NBIX is 119.85 while Neurocrine Biosciences 20-day EMA is 127.93, which makes it a Sell.
- Neurocrine Biosciences 50-day exponential moving average is 134.98 while NBIX share price is 119.85, making it a Sell technically.
- NBIX stock price is 119.85 and Neurocrine Biosciences 200-day simple moving average is 133.19, creating a Sell signal.
Fundamental Analysis of Neurocrine Biosciences
Is Neurocrine Biosciences a good investment?
- Analysts estimate an earnings increase this quarter of $0.48 per share, an increase next quarter of $0.36 per share, an increase this year of $2.34 per share, and an increase next year of $1.55 per share.
Technical Analysis of Neurocrine Biosciences
Should I short Neurocrine Biosciences stock?
- NBIX Moving Average Covergence Divergence (MACD) indicator is -6.27, suggesting Neurocrine Biosciences is a Sell
- Neurocrine Biosciences Relative Strength Index (RSI) is 30.83, which suggest Neurocrine Biosciences is oversold
- The Bollinger Bands (25) for Neurocrine Biosciences is (119.79 - 147.07), which suggest Neurocrine Biosciences is a Sell
- The Bollinger Bands (100) for Neurocrine Biosciences is (130.14 - 147.58), which suggest Neurocrine Biosciences is a Sell
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.